Manipal Hospitals
Ocrevus (ocrelizumab) in India typically costs from $18,200 to $23,800. The final price depends on whether the medication is sourced through hospital channels or distributors. In the US, this treatment costs $80,000 on average. Patients can achieve savings of approximately 74%. In India, the cost typically includes the medication, administration fees, and basic hospital stay during the infusion.
Bookimed Expert Insight: Choosing a large network like Manipal Hospitals provides significant value for international patients. Their Bengaluru facility is Joint Commission International (JCI) accredited and ranked in Newsweek’s Best Hospitals. For those seeking cost-effective care, Manipal Goa Hospital offers services approximately 2 to 5 times lower than Western Europe. Patients benefit from specialized neurology centers that handle hundreds of complex cases annually. These institutions often include additional services like free airport transfers and interpreters for international visitors.
| India | Turkey | Austria | |
| Ocrevus (ocrelizumab) | ≈ $18,200 | ≈ $4,500 | ≈ $8,800 |
No hidden fees – just official clinic prices. Pay at the clinic for Ocrevus (ocrelizumab) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ocrevus (ocrelizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ocrevus (ocrelizumab) journey.
Day 1: Arrival
Day 2: Pre-Operation
Day 3: Ocrevus (ocrelizumab) Infusion
Week 1-2: Post-Operation
Week 3-4: Rehabilitation
Please note that each patient"s experience with Ocrevus (ocrelizumab) can differ. Always consult with your healthcare team for personalized advice.
Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Ocrevus (ocrelizumab) in India by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Ocrevus (ocrelizumab) in India, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.
Performed 10,000+ major surgeries over 15 years, with special focus on gastrointestinal cancer. Dr. Banswal is known for his patient-friendly and ethical approach.
Dr. Shruti Kate specializes in immunotherapy and metronomic therapy for advanced cancers, with training from Tata Memorial Hospital – India's leading cancer center.
Dr. Chaitainya Borde has handled more than 30,000 PET scans and 1,000 thyroid cancer patients at HCG Manavata Cancer Centre.
Dr. Nagarkar has performed 50,000+ cancer surgeries with 30 years of experience – focusing on breast and thoracic oncology.
According to Bookimed, India is a good place for Ocrevus (ocrelizumab) treatment. Manipal Hospitals, one of the leading healthcare centers in India, annually serves about 2,000,000 patients from India and abroad.
Many patients who traveled to India for medical treatment expressed their gratitude for the help provided by Bookimed, such as arranging the visit and providing support throughout the process. The patients were satisfied with the work of Indian doctors, medical personnel, and Russian-speaking specialists. However, there were some concerns about translation services and waiting times for appointments.
Despite these issues, India is a popular destination for medical tourists. In 2017, India received over 495,056 medical tourists, with the majority coming from Bangladesh, Afghanistan, and the Maldives. The success rate of treatments in India is high, and the cost of treatment is significantly lower compared to other countries. Therefore, India is a good option for those seeking Ocrevus (ocrelizumab) treatment.
Bookimed's rating has revealed the top 5 hospitals in India for Ocrevus (ocrelizumab):
Bookimed has identified the top doctors in India who excel in performing Ocrevus (ocrelizumab):